| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $56.05M | - | |
| Dir | 108.7K | $7.10M | - | |
| COO | 79.2K | $5.17M | - | |
| Other | 56.8K | $3.71M | - | |
| Other | 24.3K | $1.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 | Whitfield Dianne C. | Chief Human Resources Officer | Sell | 6,711 | $47.88 | $321,323.02 | -4.4% | -17.7% | +29.3% | |
| Aug 12, 2024 | Link William J Phd | Director | Sell | 35,000 | $26.08 | $912,960.92 | -87.5% | +87.3% | +96.0% | |
| Jun 18, 2024 | Farrow Jeffrey S | See Remarks | Sale+OE | 10,445 | $27.47 | $286,924.15 | -36.5% | +16.9% | +50.5% | |
| Mar 18, 2024 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sale+OE | 10,415 | $30.60 | $318,699.00 | -28.2% | -5.8% | +50.8% | |
| Mar 18, 2024 | Whitfield Dianne C. | Chief Human Resources Officer | Sale+OE | 4,314 | $30.60 | $132,008.40 | -11.2% | -5.8% | +50.8% | |
| Mar 18, 2024 | Neervannan Seshadri | Chief Operating Officer | Sale+OE | 4,879 | $30.60 | $149,297.40 | -7.0% | -5.8% | +50.8% | |
| Mar 18, 2024 | Mottiwala Aziz51 | Chief Commercial Officer | Sale+OE | 4,766 | $30.60 | $145,839.60 | -8.1% | -5.8% | +50.8% | |
| Mar 18, 2024 | Wahl Bryan | General Counsel | Sale+OE | 4,436 | $30.60 | $135,741.60 | -9.8% | -5.8% | +50.8% | |
| Dec 27, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $20.22 | $161,760.00 | -1.0% | +65.3% | +165.5% | |
| Dec 20, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 40,000 | $20.27 | $810,622.80 | -2.3% | +57.5% | +159.9% |